Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
The impact of analytical treatment interruptions and trial interventions on time to viral re-suppression in people living with HIV restarting ART in cure-related clinical studies: a systematic review and meta-analysis.
Omicron XBB.1.16-Adapted Vaccine for COVID-19: Interim Immunogenicity and Safety Clinical Trial Results.
A phase III randomized controlled trial of plitidepsin, a marine derived compound, in hospitalized adults with moderate COVID-19.
Estimating the morbidity burden of imported chronic schistosomiasis among West African migrants in the Northern Metropolitan Area from Barcelona (Spain): a prospective community-based research.
Modifiable lifestyle factors and the risk of post-COVID-19 multisystem sequelae, hospitalization, and death.
Exceptional, naturally occurring HIV-1 control: Insight into a functional cure.
Vedolizumab and ART in recent HIV-1 infection unveil the role of α4β7 in reservoir size.
Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope Glycoprotein.
Impact of the 2008 economic crisis on the burden of hepatitis B and C diseases in Southern European countries.
The importance of post-COVID condition phenotypes characterization to decipher the mechanisms underlying this post-viral syndrome.